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Abstract 
CHARACTERIZATION OF VANCOMYCIN RESISTANCE IN 
STAPHYLOCOCCUS A UREUS 
By Paige McCarthy Fox 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy at Virginia Commonwealth University. 
Virginia Commonwealth University, 2006 
Major Director: Gordon L. Archer, M.D. 
Associate Dean for Research 
Professor, Division of Infectious Diseases 
Departments of Medicine and Microbiology and Immunology 
In the past decade, Staphylococcus aureus has developed two distinct vancomycin 
resistance mechanisms. First, the bacterium is capable of generating a thickened, poorly 
crosslinked cell wall that creates false targets. These targets cause vancomycin to bind at 
the periphery of the thickened peptidoglycan, allowing normal cell wall formation to 
continue at the cell membrane. Second, S. aureus has acquired genes from Enterococcus 
. . . 
Xl l l  
that encode an alternative stem peptide. The genes, known as van genes, alter the target of 
vancomycin, rendering vancomycin treatment ineffectual. 
In this work, we attempted to further characterize both mechanisms of vancomycin 
resistance. First, a potential link between up-regulated purine biosynthesis and increased 
vancomycin resistance due to a thickened cell wall was examined. Despite exploration of 
multiple mechanisms to increase purine levels within the cell, increased purine synthesis 
did not provide S. aureus with any advantage in the presence of vancomycin. However, 
during the investigation, purine biosynthesis in S. aureus was further characterized by 
confirming purR as the repressor of the purine pathway and demonstrating its sensitivity to 
niutation. 
Next, the relationship between homotypic oxacillin resistance and increased 
vancomycin resistance in the absence of the van genes was investigated. Vancomycin 
passage of two heterotypic methicillin resistant S. aureus (MRSA) caused these strains to 
convert to homotypic oxacillin resistance in the absence of oxacillin exposure. 
Additionally, conversion of heterotypic oxacillin resistant strains to homotypy by oxacillin 
passage increased strain survival in vancomycin. The SOS response was examined as the 
possible link between conversion to homotypic oxacillin resistance and increasing 
vancomycin resistance due to a thickened cell wall. The current study, however, detected 
no induction of the SOS response during vancomycin exposure. 
Lastly, the relationship between oxacillin resistance and vancomycin resistance due 
to the acquisition of the van genes was examined. In vitro and in vivo methods were 
utilized to determine the effectiveness of a combination of p-lactam antibiotics and 
xiv 
vancomycin to treat vancomycin resistant S. aureus (VRSA) infections. Combination 
therapy provided a significant advantage over untreated control or either antibiotic alone in 
the rabbit model of endocarditis. 



















































































































































